UNSPSC 85815314: Introduction of monoclonal antibody into respiratory tract, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of monoclonal antibody into respiratory tract, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0F30M

UNSPSC 85815314, Introduction of monoclonal antibody into respiratory tract, percutaneous approach, is a Commodity code with minimal recent state and local procurement activity aligned to its clinical scope. The code shows little relevant recent activity; the opportunities tagged under this code do not reflect the specific clinical intervention described in the code name, instead spanning telehealth services, general medical services, nursing home operations, and other health delivery modalities unrelated to monoclonal antibody administration.

The recent opportunities posted under this code originate from health plans, county health systems, state health authorities, and behavioral health agencies across California, Georgia, Nevada, and other states, with issuing bodies including Inland Empire Health Plan (California), DeKalb County (Georgia), Nevada Health Authority, San Mateo County, Boulder County, City of Phoenix, Fairfax County, and others. Representative recent solicitations include Inland Empire Health Plan's October 31, 2026 RFI for virtual urgent care services; Nevada Health Authority's December 10, 2026 RFP for Program of All Inclusive Care for the Elderly (PACE) operations; and San Mateo County's November 6, 2026 RFP for handheld retinal screening devices and services. The code does not support pursuit based on the clinical specificity of monoclonal antibody administration procedures—state and local procurement under this UNSPSC designation appears to reflect a tagging error or misclassification rather than actual demand for the respiratory-tract monoclonal antibody intervention the code nominally describes.